Immunotherapy and the Tumor Microenvironment in Brain Metastases from Non-Small Cell Lung Cancer: Challenges and Future Directions
Brain metastases (BMs) are a relatively common and severe complication in advanced non-small cell lung cancer (NSCLC), significantly affecting patient prognosis. Metastatic tumor cells can alter the brain tumor microenvironment (TME) to promote an immunosuppressive state, characterized by reduced in...
Saved in:
| Main Authors: | Meng Wang, Jihua Yang, Shuai Wang, Harjot Gill, Haiying Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/3/171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: The tumor microenvironment and immunotherapy for head and neck tumors
by: Yifan Jiang, et al.
Published: (2025-06-01) -
Unraveling the triad of immunotherapy, tumor microenvironment, and skeletal muscle biomechanics in oncology
by: Shuang Ma, et al.
Published: (2025-04-01) -
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy
by: Yan Yang, et al.
Published: (2025-05-01) -
Targeting immune microenvironment in cervical cancer: current research and advances
by: Zhen Zhang, et al.
Published: (2025-08-01) -
Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: a systematic review and network meta-analysis
by: Bin Liu, et al.
Published: (2025-04-01)